Weekly civic intelligence report ยท v2.2
CBD products have been added to a federal enforcement hit list alongside THC products. This represents expansion of federal drug enforcement targeting.
This event scores A=10.4 (below 25 threshold) and B=18.4 (below 25 threshold). Rule_of_law driver scores 2.5 for enforcement expansion into previously tolerated CBD market. Civil_rights scores 2.0 for impact on consumer choice and bodily autonomy in legal gray area. Capture scores 1.5 suggesting possible pharmaceutical/regulatory interest alignment. Enforcement_action mechanism provides 1.15 modifier, federal scope 1.2 modifier. However, critical details missing: no specific policy change cited, no agency named, 'hit list' is inflammatory framing without documentation. B-score elevated by outrage_bait (6) around popular CBD products and mismatch (7) between CBD's widespread legal acceptance and 'hit list' framing. Intentionality moderate (4) for conflating CBD with THC despite different legal status. Classification: Noise due to both scores below threshold, vague mechanism, routine enforcement pattern, and sensationalized framing without substantive policy change documentation.
VERIFY: Identify specific federal agency, policy document, or enforcement directive. Distinguish between CBD (legal under 2018 Farm Bill if <0.3% THC) and THC products. Determine if this represents actual policy change or routine enforcement of existing regulations on mislabeled/non-compliant products. Check if 'hit list' refers to standard FDA warning letters for regulatory violations rather than new prohibition.